Deborah Zanforlin developed ConquerX, the device that identifies up to 18 types of cancer in 15 minutes through a simple blood test
The Brazilian scientist Deborah Zanforlin has developed an innovative device called ConquerX. This chip, capable of identify up to 18 types of cancer through a simple blood test, it promises to revolutionize the medical approach to the disease.
The device provides results in just 15 minuteseliminating the need for expensive diagnostic tests such as CT scans and mammograms. Its main objective is make this technology accessible also to those who live in disadvantaged socioeconomic conditions or in remote areas.
The chip is based on a electrochemical biosensor platform that use nanoparticles to detect cancer-associated biomarkers. This technology offers a much higher level of sensitivity than traditional methods, expanding the number of tumors detectable in the initial phase, a crucial moment to increase the chances of a cure, which can come up to 70%.
The aim is to make it a solution for those with limited access to health services
Zanforlin, a graduate in Brazil, decided to leave her doctorate for start your own company in Bostonattracted by the advanced research ecosystem and international collaboration opportunities. During his entrepreneurial journey, he participated in a bootcamp at MITwhere he consolidated his idea and found the support of a team of experts from different countries.
This collaborative spirit has allowed ConquerX to evolve from an academic project to a technology ready for clinical testing. The device represents a unique solution for communities with limited access to healthcare services, thanks to its portability and reduced costs.
ConquerX is awaiting the necessary regulatory approvals, both in Brazil and the United States, to be able to be produced on a large scale. Collaborations with regulatory bodies such as Anvisa and the FDA aim to ensure that the chip meets the required safety and efficacy standards.
This invention not only promises to save thousands of lives thanks to early diagnosis, but also offers a new perspective on prevention, making medicine more accessible and sustainable. The dream of Deborah Zanforlin by apply science to the direct benefit of people it is therefore one step away from becoming a reality.
